Specifically Breaking Through the Injured Blood‐Brain Barrier With Tannic Acid‐Based Nanomedicine for Ischemic Stroke Ischemia Reperfusion Treatment
Exploration · 2025-10 · 5 (5)
DOI: 10.1002/exp.20240388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration, online erschienen am 09.09.2025. Verfasst von Xiaojing Shi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Xiangya Hospital Central South University Changsha China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Protecting neuronal mitochondria by eliminating the mitochondrial ROS (mtROS) storm is crucial to abrogate the neuronal damage cascade of ischemic stroke ischemia reperfusion (ISIR), which is a long‐standing challenge in the field of ischemic stroke (IS). Existing blood‐brain barrier (BBB) penetration methods are usually unable to distinguish between healthy brain tissue and cerebral infarction tissue, and BBB targeting is not compatible with mitochondrial targeting, resulting in a huge barrier to the specific elimination of mtROS in neuronal mitochondria in ISIR. This study introduces an elegantly designed tannic acid, polydopamine, and Mo‐based heteropolyacid ternary composite nanomedicine (TPM), which not only has a superb ability to eliminate multiple ROS thanks to the introduction of polydopamine, but also can actively recognize the injured BBB site, specifically enter the neurons in the cerebral infarction area, and then highly specifically target the mitochondria of neurons to efficiently eliminate mtROS. TPM could significantly inhibit neuronal apoptosis by protecting mitochondria and eliminate inflammation by inhibiting activation of the STING pathway, thereby significantly reducing the size of cerebral infarction. This sequential targeting of TPM from the injured BBB to neuronal mitochondria provides a promising strategy to treat ISIR in the clinical setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Xiangya Hospital Central South University Changsha China.
- Xiangya School of Pharmaceutical Sciences Central South University Changsha China.
- National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha China.
- Communication Design Royal Melbourne Institute of Technology University Melbourne Victoria Australia.
- Geriatric Medical Center People's Hospital of Ningxia Hui Autonomous Region Yinchuan Ningxia China.
- Hunan Provincial Key Laboratory of Cardiovascular Research Xiangya School of Pharmaceutical Sciences Central South University Changsha China.
ORCID-Profile: Kelong Ai
Zitieren
APA
Shi, X., Wang, S., Xiong, T., Li, R., Zheng, W., Chen, W., Zhao, T., Yang, Y., Ying, X., Qi, W., Xia, Y., Wang, J., Zhang, Y., Huang, Q., Nan, Y., & Ai, K. (2025). Specifically Breaking Through the Injured Blood‐Brain Barrier With Tannic Acid‐Based Nanomedicine for Ischemic Stroke Ischemia Reperfusion Treatment. Exploration, 5(5). https://doi.org/10.1002/exp.20240388
Vancouver
Shi X, Wang S, Xiong T, Li R, Zheng W, Chen W, et al. Specifically Breaking Through the Injured Blood‐Brain Barrier With Tannic Acid‐Based Nanomedicine for Ischemic Stroke Ischemia Reperfusion Treatment. Exploration. 2025;5(5). doi:10.1002/exp.20240388
BibTeX
@article{Shi2025,
author = {Shi, Xiaojing and Wang, Shuya and Xiong, Tingli and Li, Ruishi and Zheng, Wenxuan and Chen, Wensheng and Zhao, Tianjiao and Yang, Yongqi and Ying, Xiaohong and Qi, Weimin and Xia, Yingci and Wang, Jue and Zhang, Yuqi and Huang, Qiong and Nan, Yayun and Ai, Kelong},
title = {Specifically Breaking Through the Injured Blood‐Brain Barrier With Tannic Acid‐Based Nanomedicine for Ischemic Stroke Ischemia Reperfusion Treatment},
journal = {Exploration},
year = {2025},
volume = {5},
number = {5},
doi = {10.1002/exp.20240388}
}
EUVIMED